Sarah Oughtred Sells 22,690 Shares of FIGS (NYSE:FIGS) Stock
by Teresa Graham · The Cerbat GemFIGS, Inc. (NYSE:FIGS – Get Free Report) CFO Sarah Oughtred sold 22,690 shares of the business’s stock in a transaction that occurred on Thursday, February 5th. The shares were sold at an average price of $10.56, for a total value of $239,606.40. Following the completion of the transaction, the chief financial officer owned 821,500 shares of the company’s stock, valued at $8,675,040. This represents a 2.69% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.
Sarah Oughtred also recently made the following trade(s):
- On Wednesday, January 7th, Sarah Oughtred sold 10,515 shares of FIGS stock. The stock was sold at an average price of $11.50, for a total transaction of $120,922.50.
FIGS Price Performance
FIGS traded down $0.02 during trading on Monday, reaching $10.72. The company had a trading volume of 1,058,586 shares, compared to its average volume of 2,180,712. The company has a market cap of $1.76 billion, a P/E ratio of 107.20 and a beta of 1.29. FIGS, Inc. has a 12 month low of $3.57 and a 12 month high of $12.50. The business’s fifty day moving average price is $11.51 and its 200 day moving average price is $8.93.
FIGS (NYSE:FIGS – Get Free Report) last issued its quarterly earnings data on Thursday, November 6th. The company reported $0.05 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.03. The business had revenue of $151.66 million for the quarter, compared to analyst estimates of $142.39 million. FIGS had a net margin of 3.03% and a return on equity of 4.50%. The firm’s quarterly revenue was up 8.2% on a year-over-year basis. During the same period last year, the business posted ($0.01) earnings per share. As a group, sell-side analysts predict that FIGS, Inc. will post 0.01 EPS for the current fiscal year.
Analyst Upgrades and Downgrades
A number of analysts have recently commented on FIGS shares. Wall Street Zen upgraded FIGS from a “buy” rating to a “strong-buy” rating in a report on Saturday, January 17th. Telsey Advisory Group reissued a “market perform” rating and issued a $9.00 target price (up previously from $7.00) on shares of FIGS in a research report on Monday, November 3rd. Weiss Ratings restated a “hold (c-)” rating on shares of FIGS in a research note on Monday, December 29th. BTIG Research raised their price target on shares of FIGS from $12.00 to $15.00 and gave the stock a “buy” rating in a research note on Wednesday, December 10th. Finally, Morgan Stanley lifted their price objective on shares of FIGS from $7.50 to $8.00 and gave the company an “equal weight” rating in a report on Tuesday, January 13th. One equities research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $10.10.
Read Our Latest Report on FIGS
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. Assetmark Inc. bought a new position in FIGS in the third quarter valued at approximately $35,000. Elevated Capital Advisors LLC bought a new stake in shares of FIGS during the 4th quarter worth approximately $45,000. Quarry LP boosted its holdings in shares of FIGS by 1,876.3% in the 3rd quarter. Quarry LP now owns 7,846 shares of the company’s stock valued at $52,000 after buying an additional 7,449 shares during the last quarter. Capstone Financial Advisors Inc. acquired a new stake in shares of FIGS in the 2nd quarter valued at approximately $56,000. Finally, Hudson Bay Capital Management LP bought a new position in shares of FIGS in the second quarter valued at $61,000. 92.21% of the stock is owned by institutional investors and hedge funds.
FIGS Company Profile
FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.
Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.
See Also
- Five stocks we like better than FIGS
- NEW LAW: Congress Approves Setup For Digital Dollar?
- Your Bank Account Is No Longer Safe
- The day the gold market broke
- What a Former CIA Agent Knows About the Coming Collapse
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why